ABIGAYLE MYERS: Open Payments
NPI 1790551802 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 23 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $964 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| ABBVIE INC. | 2 | $47 |
| Genentech USA, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Janssen Biotech, Inc. | 2 | $32 |
| PFIZER INC. | 1 | $32 |
| Genmab U.S., Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| EMD Serono, Inc. | 1 | $19 |
Products named: KISQALI, IBRANCE, IMBRUVICA, Polivy, Tivdak, IMFINZI, OPDUALAG, FRUZAQLA.
Industry payments across OH — which companies pay providers there.
